AliveCor

Pharma, digital
By  Laura Lovett 02:50 pm February 16, 2021
Pharma giant AstraZeneca is teaming up with AliveCor, maker of artificial intelligence-enabled personal ECG devices, in an effort to study new ways of managing cardio, renal and metabolic issues. The partnership will revolve around AliveCor’s Kardia-K AI, which is designed to analyze ECGs in order to measure a patient’s potassium levels without needing to draw blood from the patient. Specifically...
The company hopes that its more descriptive reports will distinguish the personal ECG offering from others limited to atrial fibrillation detection alone.
By  Dave Muoio 01:50 pm February 1, 2021
AliveCor has updated the capabilities of its mobile ECG devices to identify three additional types of heart conditions, the company announced today. Sinus rhythm with supraventricular ectopy (SVE), sinus rhythm with premature ventricular contractions (PVCs) and sinus rhythm with wide QRS are now all on the table of AliveCor's KardiaMobile line of ECG devices, which already detected atrial...
An Apple Watch Series 5
By  Dave Muoio 12:46 pm December 8, 2020
Roughly two years after Apple brought an ECG monitor to its wrist-worn devices, connected ECG device-maker AliveCor has raised a patent lawsuit against the tech giant. Filed yesterday in the U.S. District Court for the Western District of Texas, the suit argues that the tools included in the Apple Watch Series 4 and later devices infringe on three patents held by AliveCor, all of which focus on...
FDA
By  Laura Lovett 02:25 pm November 23, 2020
Cardio-focused digital health company AliveCor landed FDA clearance for its new suite of interpretive ECG algorithms, dubbed the Kardia AI V2. This news comes just days after the company announced a $65 million Series E funding round. The new clearance will is able to capture sinus rhythm with premature ventricular contractions, sinus rhythm with supraventricular ectopy and a sinus rhythm with...
Also: Upfront Healthcare announces $11.5M in funding; Solv scores $27M and adds to its team; Levels gets $12M in a seed round.
By  Mallory Hackett 12:49 pm November 17, 2020
AliveCor, a maker of artificial intelligence-enabled personal ECG devices, has announced its Series E financing round worth $65 million. The round was led by existing investors OMRON, Khosla Ventures, WP Global Partners, Qualcomm Ventures and Bold Capital Partners. The capital will be used to enhance the growth of AliveCor’s remote-cardiology platform by adding telehealth, detection and condition...
Group applying for a job
By  MobiHealthNews 02:43 pm November 11, 2020
Healthcare voice AI company Suki recently fleshed out its leadership team with six new appointments. Chief among these are Tracy Rentz, former VP of implementation at Evolent Health, as Suki's VP of customer success and operations; former Qventus Regional Director Brian Duffy as Suki's director of Sales-East; and Brent Jarkowski, previously the senior client development director at Kyyrus, as...
By  Mallory Hackett 03:11 pm July 9, 2020
AliveCor released today KardiaCare, a digital subscription service for managing heart health at home. The service offers a suite of features that helps users interpret their heart data, monitor risk factors, identify symptom triggers and measure the impact of lifestyle changes. It will expand upon the features already provided with the company’s other ECG products, KardiaMobile and KardiaMobile...
By  Dave Muoio 04:18 pm November 22, 2019
There are few clinical areas more in need of innovation than heart disease. It’s the leading killer among men and women in the US, accounting for one in every four deaths by the CDC’s numbers, and yet it’s also a body of health conditions that could be substantially mitigated through a number of lifestyle and behavior changes. So of course it’s little surprise that cardiovascular health and care...
By  Laura Lovett 03:37 pm October 31, 2019
Digital ECG maker AliveCor is teaming up with Chinese wearable company Huami Corporation on a new effort to combine the pair’s technology into medical-grade wearables.  The end goal is to have an ECG-enabled wearable with various heart features on the market by 2020.   "AliveCor's agreement with Huami achieves our corporate goal of delivering AliveCor's AI-driven subscription services and...
By  Laura Lovett 04:25 pm October 22, 2019
Yesterday an SEC filing revealed that AliveCore, mobile ECG maker, raised $5.78 million in new funds. The filing, which was first spotted by Exits & Outcomes’ Brian Dolan, lists the company’s total offerings at $9.1 million, leaving roughly $3.4 million left on the table to be sold to potential investors. This investment grows on the $30 million it raised in 2017, which was led by the Mayo...